Trade unpredictability exposes vulnerabilities in the pharmaceutical supply chain that must be addressed to build resilient systems ensuring patient access despite geopolitical challenges.

Mark Trainor, senior director of global transformation and technology with AstraZeneca, tells how the pharmaceutical giant transformed its planning function with the help of OMP.

The administration accused companies of pushing for a speedy schedule out of an “apparent desire to be the center of attention” in the future proceedings before the trade court.

The uplift to 15%, announced by Trump one day later after the 10% rate, has yet to be implemented, but could be introduced at any time.

“We have tariffs,” President Trump said. “We just have them in a different way.”

Among the major questions left unanswered for U.S. importers are how they recoup the money the government collected over the past year.

The vote on February 11 represents an increase in political pressure to change course on Trump’s signature economic policy just months before the midterm elections.

The plant is scheduled to open sometime in 2031, as part of the company's larger push to expand its production capacity for obesity drugs that have exploded in popularity.

Three major policy and market forces are shaping the pharmaceutical landscape in 2026.